Literature DB >> 16099328

Hypersplenism in schistosomatic portal hypertension.

Andy Petroianu1, Antônio Eustaquio De Oliveira, Luiz Ronaldo Alberti.   

Abstract

BACKGROUND: For many years, the hematologic changes occurring in hepatosplenic Manson's schistosomiasis have been defined as hypersplenism. Initially, the belief was that removal of the spleen would normalize the hematologic values. However, hematimetric normalization was observed in surgeries for the treatment of portal hypertension in which the spleen was preserved. In view of these findings, it is necessary to verify the clinical and laboratory profile of these patients in order to define the real presence of hypersplenism.
METHODS: This study was conducted on 51 patients with schistosomatic portal hypertension divided into five groups: group 1, non-operated patients under clinical control; group 2, patients submitted to distal splenorenal shunt; group 3, patients with subtotal splenectomy and central splenorenal shunt; group 4, patients with total splenectomy and central splenorenal shunt; and group 5, patients with total splenectomy and portal-variceal disconnection. Clinical signs of hypersplenism were assessed in all patients. Hematologic values of the pre- and postoperative period were compared. Immunoglobulin counts of the patients were verified in the late postoperative period.
RESULTS: In all operated groups, hematimetric values, leukocyte counts, platelet number and prothrombin time were higher during the postoperative period. With respect to the immunoglobulins, the postoperative values of IgM, IgG and IgA were normal.
CONCLUSIONS: Patients with schistosomatic portal hypertension and peripheral cytopenia cannot be classified as having hypersplenism but rather as having pancytopenia due to splenomegaly caused by difficulty on portal blood drainage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099328     DOI: 10.1016/j.arcmed.2005.04.003

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  12 in total

1.  Long-term results of esophagogastric devascularization and splenectomy associated with endoscopic treatment in schistosomal portal hypertension.

Authors:  Fabio Ferrari Makdissi; Paulo Herman; Vincenzo Pugliese; Roberto de Cleva; William Abrão Saad; Ivan Cecconello; Luiz Augusto Carneiro D'Albuquerque
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

2.  Dissecting pathways to thrombocytopenia in a mouse model of visceral leishmaniasis.

Authors:  Gulab Fatima Rani; Olivier Preham; Helen Ashwin; Najmeeyah Brown; Ian S Hitchcock; Paul M Kaye
Journal:  Blood Adv       Date:  2021-03-23

3.  Subtotal splenectomy and central splenorenal shunt for treatment of bleeding from Roux en Y jejunal loop varices secondary to portal hypertension.

Authors:  João Baptista Rezende-Neto; Andy Petroianu; Sandra Kelly Santana
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

4.  Subtotal splenectomy for splenomegaly in cirrhotic patients.

Authors:  Haibo Chu; Xiaofang Liu; Jianhua Zhao; Yongbo Xu; Lei Wang; Tao Wang; Wenjun Guo; Shengming Zhang; Xiaoji Zhu
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

Review 5.  Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature.

Authors:  Francesca Tamarozzi; Veronica A Fittipaldo; Hans Martin Orth; Joachim Richter; Dora Buonfrate; Niccolò Riccardi; Federico G Gobbi
Journal:  PLoS Negl Trop Dis       Date:  2021-03-25

6.  Subtotal splenectomy preserving the inferior splenic pole for the treatment of Hodgkin's lymphoma.

Authors:  Andy Petroianu
Journal:  Int J Surg Case Rep       Date:  2017-04-25

Review 7.  TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature.

Authors:  Tamara Nordmann; Stefan Schlabe; Torsten Feldt; Federico Gobbi; Andreas Krieg; Johannes G Bode; Andre Fuchs; Christian Kraef; Michael Praktiknjo; Jonel Trebicka; Michael Ramharter; Marylyn M Addo; Christian Strassburg; Ansgar W Lohse; Tom Luedde; Stefan Schmiedel; Hans Martin Orth
Journal:  PLoS Negl Trop Dis       Date:  2021-12-21

8.  Splenectomy is associated with sexual dysfunctions and decreased libido.

Authors:  Kelly Renata Sabino; Andy Petroianu
Journal:  Sci Rep       Date:  2021-11-05       Impact factor: 4.379

9.  Splenosis after splenectomy and spleen tissue autoimplantation: Late followup study.

Authors:  Carlos T Brandt; S C S Brandão; A L C Domingues; L A Gondra; R A Viana
Journal:  J Indian Assoc Pediatr Surg       Date:  2012-07

10.  Subtotal splenectomy for the treatment of chronic lymphocytic leukemia.

Authors:  A Petroianu
Journal:  Blood Cancer J       Date:  2015-03-13       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.